Skip to main content
. 2013 Oct 21;31(34):4306–4310. doi: 10.1200/JCO.2013.51.7250

Table 1.

Pretreatment Characteristics

Characteristic No. of Eligible Patients (N = 518) %
Age, years
    Median 61
    Range 23-79
Sex
    Male 467 90
    Female 51 10
Race
    White 474 92
    Other 44 9
Primary site
    Middle third 11 2
    Lower third 170 33
    Gastroesophageal junction 337 65
Histology
    Adenocarcinoma 518 100
Histologic grade
    Well to moderate 230 44
    Poor 287 55
    Unspecified 1 0.2
Pretreatment clinical stage
    X* 21 4
    I 2 0.4
    II 202 39
    III 268 52
    IVa 25 5

NOTE. Because of rounding, the total may not add up to 100%.

*

X could not be finalized.